Daniel DeAngelo

Daniel J. DeAngelo, MD, PhD

Dana-Farber Cancer Institute

Panelist

Financial Disclosure

Amgen, Autolos, Blueprint, Forty-Seven, Gilead, Incyte, Jazz, Novartis, Pfizer, Servier, and Takeda

Consultant

I receive research funding from Abbvie, Novartis and Blueprint Pharmaceuticals

Contractor

I am on the DSMB for Daiichi-Sankyo. Mt Sinai MPN Consortium

Professional Service